The above article was sent to subscribers in Pharmacy Daily's issue from 02 Jun 10
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 02 Jun 10
THE Pharmaceutical Society of Australia (PSA) and Royal Australian College of GPs (RACGP) and have joined forces to call on major parties to fund general practice-based pharmacists to work with specialist GPs to support high-quality prescribing and quality use of medicines.
RADICAVA IV infusion (edaravone, Teva Pharma) is now listed on the Pharmaceutical Benefits Scheme (PBS) for eligible adults with amyotrophic lateral sclerosis (ALS), representing the first new PBS-listed molecule for the treatment of ALS in over 20 years.
A NEW visual identity designed to reflect Bioderma’s 45-year legacy of dermatological innovation has been launched by the French skincare brand.
FREE Pharmacy Daily subscription - never miss another story!
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.
Notifications